2025-04026Notice

FDA Extends Buzz on Trial Rules: More Time for Clinical Feedback

Published Date: 3/13/2025

Notice

Summary

The FDA is giving everyone more time to share their thoughts on the new draft rules for running safe and smart clinical trials, called E6(R3) Good Clinical Practice: Annex 2. This update mainly affects drug makers and researchers who want to make sure their studies follow the latest safety and quality standards. If you’re involved in clinical trials, now’s the chance to speak up before the new rules get finalized—no extra costs yet, just a heads-up to get ready!

No Economic Impacts Identified for this Document

Personalized for You

How does this regulation affect your finances?

Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Key Dates

Published Date
3/13/2025

Department and Agencies

Department
Independent Agency
Agency
Health and Human Services Department
Food and Drug Administration
Source: View HTML

Related Federal Register Documents

Previous / Next Documents

Back to Federal Register